What Should QA Teams Prepare Before an Unannounced Inspection Occurs?

Prepare as if inspections are always possible. QA teams must keep documentation current, systems validated, staff trained, and evidence traceable. Regulators are performing more unannounced checks globally, so build continuous inspection readiness across people, processes, and technology to reduce risk, speed responses, and protect patients.

What Should QA Teams Prepare Before an Unannounced Inspection Occurs?

Unannounced inspections are no longer an occasional stress-test; they are part of the normal regulatory landscape. For pharma and medical devices and pharmaceutical manufacturers, the practical question is not whether an inspection will happen, but how ready your team will be the moment an investigator walks through the door. This article provides a comprehensive, expert-level guide, written in straightforward language, on how QA teams should prepare, what to prioritize, and which metrics and processes will protect your site, product, and company's reputation.

Where relevant, I'll draw on current industry signals (regulator activity, inspection trends, and recent enforcement examples) and include a clear roadmap and checklists you can act on immediately.

Key regulator context to keep in mind

• The FDA has indicated it conducts roughly 12,000 domestic inspections and about 3,000 foreign inspections annually. The agency has also expanded the use of unannounced inspections at foreign manufacturing sites. This expansion increases the chance that any given foreign facility may receive an unannounced visit.
• In the EU, the EMA performed more than 200 GMP inspections in 2024 and continues to use on-site inspections to enforce GMP and supply-chain integrity.

Quick visual: FDA inspection volumes, domestic vs foreign (approximate, recent years).

1. Accept reality: inspections may be unannounced, and always operate in a steady state of readiness

First, change the team's mindset. Unannounced inspections are designed to see how you really operate, not how you perform when you have advance notice. Investigators want to observe routine behavior. Therefore, QA readiness has to be a daily activity and not a last-minute scramble.

Why this matters now

• Regulators are increasing unannounced foreign inspections and focusing on data integrity and GMP fundamentals. Findings that previously appeared mostly at domestic inspections are being discovered overseas as regulators intensify oversight. This makes a steady, auditable state of readiness an operational necessity.

Practical change in mindset:

• Replace "inspection prep" projects with living processes: daily documentation discipline, routine verification of critical systems, and ongoing staff readiness.

2. Documentation: make everything findable, correct, and defensible

Documentation failures are among the most common root causes of inspection citations. An unannounced inspection will start with requests for SOPs, batch records, logs, training records, and CAPA files. If these are incomplete or hard to find, investigators will dig deeper.

What to prioritize

• Master Documents & SOPs: Ensure the current approved versions are available in both electronic and printed form where required. Cross-reference each SOP to the process owners and training logs.
• Batch Records and Manufacturing Documentation: All entries must be complete, legible, timed, and signed. Missing initials, undated entries, or retrospective changes are red flags.
• Training Records: Training should be current and tied to job descriptions. Keep proof of on-the-job competence, not just attendance.
• Calibration & Maintenance Logs: Instruments, monitoring systems, and critical utilities must have up-to-date calibration certificates, service logs, and qualification records.
• Change Control Documents: Show the formal process for changes, including risk assessments, approvals, and impact analyses.

Checklist for quick verification (daily/weekly)

• Are the last 10 batch records fully closed and archived with signatures?
• Are calibration tags visible on critical instruments?
• Are recent deviations logged and assigned with target dates?
• Are training modules for critical roles signed and traceable to personnel records?

Evidence that investigators expect

• A single, consistent source of truth for each document type (e.g., an electronic document management system with role-based access and audit trails)

3. Systems and data integrity, the backbone of modern inspections

Modern inspections focus heavily on data integrity. Regulators want to see ALCOA+ (Attributable, Legible, Contemporaneous, Original, Accurate, and additional attributes) practices applied to electronic and paper records alike. The FDA and other authorities have highlighted data integrity as a repeated source of deficiencies.

Steps to protect data integrity

• Audit trails: Ensure all electronic systems record who accessed or changed data, with timestamps and reasons. Periodically review audit trails and document the reviews.
• Backups and retention: Have documented backup policies and verify recovery procedures. If auditors request historical data snapshots, you must be able to provide them intact.
• Access control: Enforce least privilege, timely off-boarding, and role-based access. Reconcile user lists quarterly.
• Instrument data: Make sure lab instruments and process devices are set to secure time, and the outputs flow into validated systems.
• Data reconciliation: Regularly reconcile LIMS, MES, and paper records. Any discrepancy must be resolved and documented before an inspection.

Current industry signal

• Form FDA-483 observations and inspection classifications show that data integrity issues remain a frequent finding. Teams must make data integrity a measurable program rather than a checkbox activity.

4. People: training, presence, and clear ownership

Investigators will talk to operators, technicians, supervisors, and management. The tone and authenticity of those interactions matter. People who can answer routine questions confidently and follow SOPs without hesitation make inspections smoother and less risky.

Training that matters for unannounced inspections

• Role-based training: Not generic training. Ensure staff can explain and demonstrate the activities they carry out.
• Mock inspections and role-play: Regular drills reduce anxiety and improve performance during real inspections.
• Escalation training: Employees must know when and how to escalate anomalies, and QA must document how escalations were handled.
• Critical thinking: Teach employees to be factual and concise in responses. Avoid speculation or providing irrelevant documents.

Staffing & presence

• Ensure you have an inspection response team roster 24/7 with appropriate alternates. For multi-shift sites, rotate inspection readiness training across shifts.

5. Facility and operational readiness

Investigators observe housekeeping, maintenance, line clearance, environmental monitoring, and contamination control practices. These visible indicators often trigger deeper scrutiny.

Facility checklist

• Housekeeping: Clean, labeled, and organized workspaces with no cross-contamination evidence.
• Material segregation: Proper storage and labeling of components and finished products.
• Environmental monitoring: Recent trend analysis and investigations for excursions.
• Pest control & utilities: Logs that show routine checks and corrective actions.
• Line clearance & changeover: Documented procedures and evidence of adherence.

Focus on what investigators will commonly check:

• Cleanroom gowning rooms and procedures.
• Batch release areas and sample retention policies.
• Waste handling and quarantine practice

6. Deviation and CAPA management, anticipate tough questions

Investigators will probe past deviations and ask for evidence of root cause analysis, corrective actions, and verification of fixes.

Best practices

• Complete investigations: Don't file a deviation and leave it open. Provide interim controls if a long-term fix is pending and document the rationale.
• Root cause rigor: Use comprehensive problem-solving tools (5 Whys, Fishbone, or FMEA) and document the analysis.
• Effectiveness checks: Show evidence that corrective actions actually worked, and list metrics used for verification.
• Trend analysis: Present deviation and CAPA trends, including actions and timelines.

Transparency is key: if there is a pending CAPA, have a clear, documented reason why the issue does not present an immediate risk to product quality.

7. Supplier and supply-chain oversight

Investigators commonly examine how you qualify suppliers, handle incoming materials, and manage contract manufacturers or testing labs.

What to prepare

• Approved supplier lists & qualification data.
• Certificates of analysis (CoA) and incoming QC results.
• Supplier audit summaries and evidence of oversight for critical suppliers.
• Agreements covering quality expectations, data access, and audit rights.

When relying on contract manufacturing organizations (CMOs) or contract testing labs, be ready to show how you maintain oversight and receive timely data.

8. Electronic Systems, Validation & Computerized Systems

Computerized systems must be validated and supported by policies. The investigator will want to see validation packages and change-control history.

Essential artifacts

• IQ/OQ/PQ packs for validated systems.
• Validation master plan (VMP).
• Change control for software updates, including risk assessments.
• Backup and disaster recovery evidence.

Investigators will target systems that generate batch and stability data, so ensure those are fully validated and traceable.

9. Lab readiness: methods, traceability, and sample handling

Quality labs are often the focal point. Investigators will review method validation, system suitability, and sample retention.

Key actions

• Method validation and SOPs: Ensure protocols and validation records match what's implemented.
• Reference standards: Document the chain-of-custody and certificate of analysis for standards.
• Sample retention and disposition: Have documented retention policies and evidence of stored samples.
• Equipment calibration and maintenance: Confirm that instruments used for release testing are current

10. Responding to the investigator: communication and documentation strategy

When an investigator arrives, the team's immediate behavior influences the inspection. Be transparent, factual, and cooperative. But also be careful: supply only the requested documents and avoid unnecessary explanations.

Guidelines

• Designate a single point of contact from QA to interface with the investigator.
• Log every request and response, note who gave the document and when.
• Do not volunteer extra documents unless asked. Provide concise, accurate answers.
• If you need time to collect documents, state a timeline and deliver within it. Delivering proactively within the timeline builds trust.
• For complex technical questions, bring the subject-matter expert to the discussion.

Atlas

See what the FDA knows about your next investigator.

30 minutes with the founder. No pitch deck.

See it live

11. After the inspection: Form 483, warning letters, and remediation

If investigators find objectionable conditions, they may issue a Form FDA-483 (or equivalent local observation list). How you respond matters greatly.

Immediate steps after receiving observations

• Acknowledge receipt and begin an internal investigation.
• Create a clear, structured response addressing each observation with root cause, corrective action, timelines, and verification plans.
• Prioritize critical fixes that directly impact product quality or patient safety.
• Document everything, investigators evaluate follow-through, not just commitments.

Industry signal: firms continue to receive warning letters and Form 483 findings when remediation is incomplete or insufficient. For example, a notable 2025 warning letter to a large device manufacturer demonstrated how inspection findings and follow-up responses can create market consequences until issues are resolved.

12. Metrics and KPIs: how to demonstrate readiness continuously

Measure what matters. Build a dashboard for leadership that shows inspection-readiness posture and trends.

Suggested KPIs

• Percent of batch records closed within the expected timeframe.
• Open CAPAs and average age.
• Audit trail review completion rate.
• Training currency percentage for critical roles.
• Document revision cycle times.
• Number of supplier audits completed vs scheduled.

These KPIs help show readiness and provide early warning if workflows drift away from compliance.

13. Mock and surprise internal audits, practice for reality

Run unannounced internal audits that mimic regulator behavior. Use cross-functional teams and an independent QC or external auditor to simulate objectivity.

How to run them

• Use a rotating audit calendar that covers all shifts and functions.
• Include off-hours and weekend checks to test true operational behavior.
• Debrief fast and close gaps quickly to demonstrate continuous improvement.

Mock audits reveal real-world patterns and fix issues before regulators see them.

14. Technology and digital improvement: Use the tools, but validate them

Digital systems (MES, LIMS, QMS) help maintain consistency, but they must be validated and secured.

Best practices

• Integrate systems for traceability, but keep clear data ownership and provenance fields.
• Use electronic signatures and audit trails to prove contemporaneous recording.
• Automate reconciliation between systems to find gaps early.
• Encrypt sensitive data and maintain secure backups.

Caution: automation without governance can amplify errors. Every automation should include monitoring and fallbacks.

15. Supply-chain and third-party risk management

Regulators often examine upstream activities. Ensure that audits of suppliers, brokers, and logistics partners are current and well-documented.

Focus areas

• Batch release responsibilities when working with CMOs.
• Import records and customs documentation if raw materials cross borders.
• Cold chain management evidence for temperature-sensitive products.

16. Communicating with regulators, build constructive relationships

While keeping rigorous controls, foster a constructive working relationship with regional investigators. Early and transparent communication can reduce misunderstandings.

Practical tips

• Be proactive during regulatory reviews, provide requested documents early and in organized bundles.
• Use inspection response to learn, update SOPs and training after every inspection.
• Maintain an inspection readiness contact who stays current with regulator expectations and training, including familiarity with investigator history and profiles.

17. Real-world signals & trends (recent data and news)

• Regulators continue to expand unannounced inspection programs globally, increasing the chance of in-the-moment checks at foreign sites. This change has been driven by concerns over data integrity and product quality in complex global supply chains.
• Analyses of inspection trends show increases in enforcement actions and a higher proportion of serious inspection outcomes in some regions, reinforcing the importance of preparedness.
• Industry surveys indicate that companies increasingly rely on investigator-friendly digital evidence packages and well-documented provider oversight to reduce inspection friction. For example, regional industry surveys show reliance on remote and targeted inspections is growing, and companies are adjusting audit cadence.

These trends support the need to build a continuous inspection readiness program rather than a reactive posture.

18. Practical 48-hour checklist: what to do immediately if you suspect an inspection is imminent

1. Notify the inspection response team and assemble key personnel.
2. Secure and index the last 12 months of SOPs, batch records, deviations, CAPAs, and training files.
3. Verify critical instrument calibrations and validation status (last 3 months).
4. Confirm backups and data availability for LIMS/MES/QMS.
5. Prepare a concise site map and provide a single point of contact.
6. Review open CAPAs for any product-impacting issues and prepare talking points.
7. Ensure facilities are physically inspection-ready (housekeeping, labeling, sample storage).
8. Prepare evidence bundles for commonly requested items (batch record package, stability data, validation pack).

This checklist is designed to stabilize operations quickly and transparently.

19. Long-term program: how to embed inspection readiness into operations

• Daily discipline: integrate checks into shift handover notes and shift KPIs.
• Continuous improvement: use inspection outcomes and mock audits as inputs into QMS metrics and training content.
• Data-driven audits: use system data to prioritize audits where risk metrics are highest.
• Governance: Create an inspection-readiness steering committee that reports monthly to senior management.

20. Final practical advice, what leadership must enable

• Provide resourcing: inspections require people, not just processes. Invest in a staffed inspection readiness function.
• Give QA authority: QA must be able to stop lines or quarantine product when risk appears.
• Monitor supplier risk: fund supplier audits and remediation.
• Invest in systems: validated, integrated electronic systems reduce manual errors and speed responses.
• Celebrate readiness wins: reward teams that maintain continuous compliance and avoid inspection findings.

Five Frequently Asked Questions (FAQs)

1. How likely is an unannounced inspection at my foreign manufacturing site?
Regulators are increasing unannounced foreign inspections. The FDA's expanded program and similar global efforts make it more likely; consider any site with global distribution as at risk.

2. Should we keep paper records or go fully electronic to be ready?
Both can work. Electronic systems with validated audit trails and backups speed retrieval and evidence assembly. However, if you use paper, ensure rigorous controls, contemporaneous entries, and secure archival practices.

3. How should we handle investigator requests for electronic files?
Designate a single point of contact, log the request, and deliver the requested files in a structured evidence bundle. Avoid over-sharing; provide what is requested and keep a documented chain-of-custody.

4. What is the fastest way to fix a Form 483 observation?
Respond quickly with a clear root cause, corrective actions, timelines, and verification plans. Prioritize fixes that affect product quality and patient safety first.

5. How often should we run mock unannounced internal audits?
Quarterly mock audits are a good baseline, with additional surprise checks for high-risk processes and night or weekend shifts.

Unannounced inspections are an operational reality. The difference between a minor observation and a major regulatory action often lies in the programmatic discipline of the QA team. Build continuous readiness into daily work, focus on data integrity, train staff for real-world interactions, and document every step. These actions preserve patient safety, reduce business interruption, and protect your reputation.

Atlas helps QA teams stay prepared.
With near-real-time FDA inspection and enforcement data, Form 483 insights, and compliance updates, Atlas makes it easier for pharma and medical device companies to stay audit-ready every day.